Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth
Geographical Focus
United States, United Kingdom, Germany, Hong Kong, China, Indonesia, Russia, Philippines, Israel
Industries Focus
- E-commerce
- Digital Health
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Health and Wellness
- Consumer Health
- Healthcare IT
- Telemedicine
- Chronic Condition Management
- Point-of-Care Diagnostics
- Pregnancy Support
- Smart Dieting
- Pain Treatment
- Retail Health
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2018
Longliv Ventures is a consumer-oriented digital health fund that focuses on investments in early-stage ventures aiming to address significant health and wellness issues with global impact. As a member of the CK Hutchison Holdings Group, Longliv Ventures leverages the group's extensive resources and expertise to support innovative companies in the healthcare sector. The fund's portfolio includes investments in areas such as telemedicine, chronic condition management, point-of-care diagnostics, and smart dieting solutions. By providing strategic guidance and access to a vast network, Longliv Ventures assists entrepreneurs in scaling their solutions to a global audience. The fund's commitment to advancing healthcare through technology is evident in its support for companies like Sight Diagnostics Ltd, which is transforming point-of-care diagnostics, and DayTwo, a microbiome-based platform for personalized dietary interventions. Through these investments, Longliv Ventures demonstrates its dedication to improving health outcomes worldwide by empowering consumers to take control of their health through innovative digital solutions.
Longliv Ventures' strategic approach combines deep knowledge of technology, strategy, regulation, and digital platforms to add significant value to its portfolio companies. The fund's affiliation with the CK Hutchison Holdings Group, a multinational conglomerate with a pivotal role in healthcare through its A.S. Watson Division, provides unique opportunities for startups to access a global customer base. This partnership enables Longliv Ventures to offer its portfolio companies unparalleled market reach and resources, facilitating their growth and success in the competitive digital health landscape. By focusing on early-stage investments, Longliv Ventures plays a crucial role in nurturing and scaling innovative solutions that address pressing health and wellness challenges, contributing to the advancement of global healthcare.
Through its strategic investments and comprehensive support, Longliv Ventures exemplifies a commitment to fostering innovation in the healthcare sector. The fund's proactive approach in identifying and supporting visionary entrepreneurs underscores its dedication to driving positive change in health and wellness worldwide. By leveraging its extensive network and resources, Longliv Ventures continues to empower startups to bring transformative solutions to market, enhancing the quality of healthcare and improving lives globally.
Requirements
- Innovative solutions addressing significant health and wellness challenges
- Early-stage ventures with global impact potential
- Alignment with digital health and technology sectors
- Scalable business models with potential for rapid growth
- Strong management teams with proven expertise in healthcare and technology
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Sight Diagnostics Ltd
- DayTwo
- Apowiser
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$9.95
-
$49.95
-
$19.95
-
$39.95
Claim this Investor
Are you an official representative of Longliv Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim